Skip to main content

Bioscreen to Distribute Labcyte Systems in India

NEW YORK (GenomeWeb News) – Bioscreen Instruments will distribute Labcyte’s acoustic liquid transfer systems in India, Labcyte said today.

The distribution agreement will help “further broaden our existing user base in the pharmaceutical industry and the contract research organizations that service them,” Labcyte’s VP of Sales, Marketing, and Service, Stephen Bates, said in a statement.

Chennai, India-based Bioscreen will provide the Labcyte technology for compound management and high-throughput and secondary screening research, Bates said.

Bioscreen is a life sciences provider focused on providing drug discovery, genomics, and proteomics technologies.

Nick Samaras, Labcyte’s Asia-Pacific Managing Director, said that the firm's platform also may be used in areas such as imaging mass spectrometry, array formation, compound microencapsulation, particle production, proteomics research, and cell-based biology.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.